Dr Reddy’s gets 30 days to sell ‘Olymviq’ stock in Novo trademark case

by | March 29, 2026 2:09 pm | Indian Stocks, Market, News

Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk.